CRL — Charles River Laboratories International Cashflow Statement
0.000.00%
- $8.32bn
- $10.29bn
- $4.02bn
- 87
- 47
- 85
- 85
Annual cashflow statement for Charles River Laboratories International, fiscal year end - December 27th, USD millions except per share, conversion factor applied.
2021 December 25th | 2022 December 31st | 2023 December 30th | 2024 December 28th | 2025 December 27th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 399 | 493 | 480 | 25.3 | -142 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 77.5 | 11.6 | 42.7 | 445 | 538 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 42.9 | -153 | -102 | -30.3 | 14.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 761 | 620 | 684 | 735 | 738 |
| Capital Expenditures | -229 | -325 | -319 | -233 | -219 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,209 | -283 | -245 | -12.1 | 9.83 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,438 | -608 | -563 | -245 | -209 |
| Financing Cash Flow Items | -40.6 | -48.6 | -11.6 | -43.4 | -55 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 673 | -42.4 | -85.5 | -551 | -537 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.2 | -5.1 | 43.3 | -78.9 | 10.4 |